NSN 6505-01-618-5356, 6505016185356
EMTRICITABINE AND TENOFOVIR TABL

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 016185356
Codification Country: United States
Item Name Code: INC 77777
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-618-5356

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-618-5356

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-618-5356

National Stock Number (NSN) 6505-01-618-5356, or NIIN 016185356, (emtricitabine and tenofovir tabl) was assigned April 26, 2013 in the Federal Logistics Information System (FLIS). This NSN does not replace any other NSNs.

There are 7 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 5 suppliers. Today, 5 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 5 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over a year. There have been 9 contracts issued for this part number, with 9 awards given. There is minimal competition for this NSN. The US Government has awarded contracts to 2 different suppliers. The last contract numbers awarded were: SPE2DP23F6026, SPE2DP18F0691, SPE2DX15D9383, SPE2DX15D9383, SPE2DP16V0721. The total value of the awarded contracts has been US$ 26,366.99.

There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Aug 16, 2014, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 77777. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505016185356 does not contain precious metals.

This information was last updated on Aug 01, 2025.

Technical Characteristics

PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) EMTRICITABINE/TENFOVIR (200MG/300MG) TABS 30S
PROTECTIVE STORAGE FEATURE: (AJCN) CONTROLLED ROOM TEMPERATURE
SPECIAL FEATURES: (FEAT) 200MG EMTRICITABINE AND 300MG OF TENOFOVIR DISOPROXIL FUMARATE; 30 TABLETS PER BOTTLE; TAKEN ORALLY; COMBINATION OF EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE IS INDICATED IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS (SUCH AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OR PROTEASE INHIBITORS) FOR THE TREATMENT OF HIV-1 INFECTION IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER; ALSO APPROVED FOR USE IN COMBINATION WITH SAFER SEX PRACTICES FOR PRE-EXPOSURE PROPHYLAXIS (PREP), TO REDUCE THE RISK OF SEXUALLY ACQUIRED HIV-1 INFECTION IN ADULTS AT HIGH RISK